Home » Stocks » DHR

Danaher Corporation (DHR)

Stock Price: $240.94 USD -2.12 (-0.87%)
Updated Apr 19, 2021 1:46 PM EDT - Market open
Market Cap 173.32B
Revenue (ttm) 22.28B
Net Income (ttm) 3.51B
Shares Out 706.20M
EPS (ttm) 4.89
PE Ratio 49.32
Forward PE 30.96
Dividend $0.72
Dividend Yield 0.30%
Trading Day April 19
Last Price $240.94
Previous Close $243.06
Change ($) -2.12
Change (%) -0.87%
Day's Open 241.84
Day's Range 239.95 - 242.72
Day's Volume 830,203
52-Week Range 150.80 - 248.62

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Danaher (DHR) benefits from strength across its businesses, acquisitions and shareholder-friendly policies. However, rising costs and expenses remain concerning.

4 days ago - Zacks Investment Research

Danaher (DHR) raises revenue projection for the first quarter of 2021 on strengthening Diagnostics and Life Sciences businesses.

5 days ago - Zacks Investment Research

Danaher (DHR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the n...

5 days ago - Zacks Investment Research

SSUMY vs. DHR: Which Stock Is the Better Value Option?

Other stocks mentioned: SSUMY
6 days ago - Zacks Investment Research

Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

6 days ago - Zacks Investment Research

WASHINGTON, April 13, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") announced today that it expects first quarter 2021 core revenue growth to be above the high-end of the Company'...

6 days ago - PRNewsWire

Although Friday is set for mixed trading, the indices are set to close the week with solid gains as the S&P continues hovering around a record high. Meanwhile, Q.ai's deep learning algorithms have broug...

Other stocks mentioned: CMG, FAST, LOW, SMTC
1 week ago - Forbes

It's certainly a hot market, but sector rotation and consolidation in select sectors means that safe stocks are now the most appealing. The post 7 Safe Stocks to Buy for Uncertain Times appeared first o...

Other stocks mentioned: AMAT, CAT, DE, LOW, TGT, TSM
1 week ago - InvestorPlace

With the trading day approaching halfway over, the broad markets were trading marginally positive.

Other stocks mentioned: ANF, PFE, TEVA, FLXN, JAZZ
1 week ago - 24/7 Wall Street

Covid-19 has put healthcare stocks in the limelight. These seven companies should be on your radar for the next pandemic.

Other stocks mentioned: GERM, GILD, HOLX, IMVT, PFE, XLV
2 weeks ago - InvestorPlace

WASHINGTON, March 25, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2021 on Thursday, April 22, 2021 be...

3 weeks ago - PRNewsWire

BREA, Calif., March 23, 2021 /PRNewswire/ -- Beckman Coulter, a clinical diagnostics leader, today announced that its Access SARS-CoV-2 IgG II antibody assay received U.S. Emergency Use Authorization (E...

3 weeks ago - PRNewsWire

BREA, Calif., March 18, 2021 /PRNewswire/ -- Beckman Coulter, a clinical diagnostics leader, today announced their commitment to support the U.S. government's plan to invest more than $12 billion to exp...

1 month ago - PRNewsWire

CORALVILLE, Iowa--(BUSINESS WIRE)--Integrated DNA Technologies (IDT), a leading comprehensive genomics solutions provider, announced today the acquisition of Swift Biosciences, a pioneer in the developm...

1 month ago - Business Wire

There are many reasons an insider might sell. But there is only one reason for insider buying; insiders think the stock will trade higher.

Other stocks mentioned: DTE, IRWD, NLS, PRMW, SNSE, TREE
1 month ago - InvestorPlace

WASHINGTON, March 4, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Matt McGrew, will be presenting at the Barclays Global Heal...

1 month ago - PRNewsWire

With the trading day about halfway over, the broad markets have not made up their minds on a direction for the day.

Other stocks mentioned: MSFT, ORCL, SPCE, TSLA, ADPT, CTXS, DOCU ...
1 month ago - 24/7 Wall Street

We have narrowed down our search to five corporate behemoths that suffered a blow in last month's turmoil. These are AAPL, MSFT, FB, ABT and DHR.

Other stocks mentioned: AAPL, ABT, FB, MSFT
1 month ago - Zacks Investment Research

Danaher (DHR) reported earnings 30 days ago. What's next for the stock?

1 month ago - Zacks Investment Research

Danaher (DHR) is poised to benefit from growth opportunities within its segments. Also, gains from acquired assets and divestments as well as shareholder-friendly policies are likely to favor.

1 month ago - Zacks Investment Research

WASHINGTON, Feb. 23, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.21 per share of its common stoc...

1 month ago - PRNewsWire

WASHINGTON, Feb. 22, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Cowen Healthcare Conference on ...

1 month ago - PRNewsWire

Players in the Zacks Diversified Operations industry are leveraging the pandemic-induced demand in the medical equipment and personal safety products markets. Also, strengthening businesses in markets l...

Other stocks mentioned: CR, GFF, MMM
2 months ago - Zacks Investment Research

Introduction: What is lean manufacturing?

Other stocks mentioned: GE
2 months ago - GuruFocus

The key to the stock's prospects will be to continue its earnings trajectory in a post-COVID-19 world.

2 months ago - The Motley Fool

Danaher Corporation (DHR) CEO Rainer Blair on Q4 2020 Results - Earnings Call Transcript

2 months ago - Seeking Alpha

Danaher's (DHR) Q4 results reflect strength in Diagnostics, Life Sciences, and Environmental & Applied Solutions segments as well as growth in margins. Core sales growth projections are impressive.

2 months ago - Zacks Investment Research

Danaher (DHR) delivered earnings and revenue surprises of 13.04% and 0.10%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

WASHINGTON, Jan. 28, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the fourth quarter and full year 2020. All results in this release reflect only cont...

2 months ago - PRNewsWire

Danaher (DHR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

2 months ago - Zacks Investment Research

Six stocks are set to beat fourth-quarter earnings estimates tomorrow. These are: DHR, DOV, OLN, PHM, HTH, NATI.

Other stocks mentioned: DOV, HTH, NATI, OLN, PHM
2 months ago - Zacks Investment Research

It's not easy to beat every quarter on earnings for five years, including during a global pandemic. These companies have done it.

Other stocks mentioned: ABT, JCI, NOW, SWK
2 months ago - Zacks Investment Research

Danaher (DHR) Q4 results to reflect benefits from solid Diagnostics and Life Sciences demand. Also, positive impacts of acquired assets and foreign currency translations are likely to have aided.

2 months ago - Zacks Investment Research

The Danaher Corporation uses a continuous improvement strategy called the Danaher Business System. After starting as a Lean Manufacturing practice, it evolved and expanded into a system that affects eve...

3 months ago - Seeking Alpha

Danaher Corporation (DHR) CEO Rainer Blair Presents at J.P. Morgan Healthcare Conference Call Transcript

3 months ago - Seeking Alpha

WASHINGTON, Jan. 13, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") announced that its President and Chief Executive Officer, Rainer M. Blair, will comment today on the Company's f...

3 months ago - PRNewsWire

We have narrowed down our search to seven corporate behemoths that have strong growth potential in 2021. These are: TSLA, SQ, NVDA, FB, AVGO, DHR and QCOM.

Other stocks mentioned: AVGO, GOOGL, NVDA, QCOM, SQ, TSLA, GOOG
3 months ago - Zacks Investment Research

Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

3 months ago - Zacks Investment Research

WASHINGTON, Jan. 7, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P. Morgan Healthcare Conferenc...

3 months ago - PRNewsWire

WASHINGTON, Jan. 7, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the fourth quarter 2020 on Thursday, January 28, 2021 b...

3 months ago - PRNewsWire

We have selected eight stocks that have strong strong potential for 2021 and beyond. These are: DE, MU, GM, TSLA, FDX, NVDA, DHR and GOOGL.

Other stocks mentioned: DE, FDX, GM, GOOGL, MU, NVDA, TSLA
3 months ago - Zacks Investment Research

Water doesn't typically get the same focus that I put on other utilities like electric and gas companies. Though, that doesn't mean that investing in water ETFs doesn't have its own merits; it certainly...

Other stocks mentioned: AQN, AWK, CGW, FERGY, FIW, HIE, PHO ...
3 months ago - Seeking Alpha

WASHINGTON, Dec. 21, 2020 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that Jose-Carlos ("JC") Gutierrez-Ramos has been named Senior Vice President and Chief Scientific Officer for Da...

3 months ago - PRNewsWire

We have narrowed down our search to five corporate behemoths that have popped more than 30% year to date. These are: NVDA, DHR, UPS, MSFT and AVGO.

Other stocks mentioned: AVGO, MSFT, NVDA, UPS
4 months ago - Zacks Investment Research

Three well-run companies and what investors can take away from their outperformance in the past decade.

Other stocks mentioned: ITW, ROP
4 months ago - The Motley Fool

Danaher Corporation (DHR) CEO Rainer Blair Presents at Evercore ISI 3rd Annual HealthCONx Brokers Conference (Transcript)

Other stocks mentioned: EVR
4 months ago - Seeking Alpha

Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason -- they believe the stock price will rise and they want to profit from it. So insider buying can ...

Other stocks mentioned: COTY, FL, BH, BHVN, STOK
4 months ago - Benzinga

Science and technology company Danaher Corporation (NYSE: DHR) boasts a high-quality and defensive portfolio that has become "less compelling to own" ahead of a cyclical recovery into 2021, according to...

4 months ago - Benzinga

It will be prudent to invest in large-cap stocks with a favorable Zacks Rank that are members of any of the three large-cap indexes. These are DHR, UPS, NVDA, MSFT, TGT, TMO, DE, FDX.

Other stocks mentioned: DE, FDX, MSFT, NVDA, TGT, TMO, UPS
4 months ago - Zacks Investment Research

WASHINGTON, Nov. 24, 2020 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Evercore ISI HealthCONx Confere...

4 months ago - PRNewsWire

About DHR

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to t... [Read more...]

Industry
Diagnostics & Research
Founded
1969
CEO
H. Lawrence Culp
Employees
67,000
Stock Exchange
NYSE
Ticker Symbol
DHR
Full Company Profile

Financial Performance

In 2020, Danaher's revenue was $22.28 billion, an increase of 24.42% compared to the previous year's $17.91 billion. Earnings were $3.65 billion, an increase of 21.21%.

Financial Statements

Analyst Forecasts

According to 21 analysts, the average rating for Danaher stock is "Buy." The 12-month stock price forecast is 269.12, which is an increase of 11.70% from the latest price.

Price Target
$269.12
(11.70% upside)
Analyst Consensus: Buy